 Daniel Frank
Concepts (811)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 762 | 5.770 |
Why?
| | Gastrointestinal Microbiome | 48 | 2025 | 697 | 5.390 |
Why?
| | Rhinitis | 15 | 2022 | 158 | 4.840 |
Why?
| | Sinusitis | 17 | 2023 | 221 | 4.820 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 549 | 3.200 |
Why?
| | Bacteria | 34 | 2023 | 858 | 3.190 |
Why?
| | Metagenome | 15 | 2019 | 147 | 3.130 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 80 | 2.360 |
Why?
| | Intestines | 15 | 2022 | 357 | 2.220 |
Why?
| | Dysbiosis | 18 | 2025 | 181 | 2.150 |
Why?
| | Otitis Media | 8 | 2025 | 165 | 2.140 |
Why?
| | Feces | 25 | 2025 | 484 | 1.950 |
Why?
| | Intestinal Mucosa | 20 | 2025 | 623 | 1.700 |
Why?
| | RNA, Bacterial | 12 | 2018 | 190 | 1.580 |
Why?
| | Nasal Polyps | 5 | 2021 | 59 | 1.470 |
Why?
| | Nose | 4 | 2018 | 67 | 1.420 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 450 | 1.340 |
Why?
| | Nasal Cavity | 6 | 2023 | 52 | 1.310 |
Why?
| | Ileum | 5 | 2020 | 119 | 1.220 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 812 | 1.200 |
Why?
| | Bacteremia | 6 | 2018 | 214 | 1.180 |
Why?
| | Phylogeny | 25 | 2020 | 904 | 1.130 |
Why?
| | Crohn Disease | 6 | 2020 | 243 | 1.130 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 195 | 1.070 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 400 | 1.050 |
Why?
| | Chronic Disease | 17 | 2022 | 1793 | 0.980 |
Why?
| | HIV Infections | 15 | 2025 | 2836 | 0.930 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.890 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 44 | 0.870 |
Why?
| | Clostridium Infections | 4 | 2018 | 73 | 0.830 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 41 | 0.830 |
Why?
| | Colon | 9 | 2025 | 282 | 0.820 |
Why?
| | Humans | 140 | 2025 | 137585 | 0.810 |
Why?
| | Infant Nutritional Physiological Phenomena | 4 | 2025 | 146 | 0.810 |
Why?
| | Nasopharynx | 5 | 2024 | 76 | 0.800 |
Why?
| | Endoribonucleases | 8 | 2002 | 81 | 0.790 |
Why?
| | Biodiversity | 13 | 2020 | 409 | 0.780 |
Why?
| | Breast Feeding | 7 | 2025 | 440 | 0.770 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.770 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.760 |
Why?
| | Bacterial Infections | 3 | 2015 | 250 | 0.760 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 351 | 0.740 |
Why?
| | Inflammation Mediators | 3 | 2023 | 513 | 0.740 |
Why?
| | RNA, Catalytic | 7 | 2001 | 187 | 0.730 |
Why?
| | Database Management Systems | 2 | 2013 | 51 | 0.710 |
Why?
| | Drinking Water | 1 | 2022 | 84 | 0.690 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.680 |
Why?
| | Inflammation | 13 | 2025 | 2837 | 0.680 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.680 |
Why?
| | Male | 72 | 2025 | 67762 | 0.680 |
Why?
| | User-Computer Interface | 2 | 2013 | 159 | 0.660 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 109 | 0.660 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2900 | 0.660 |
Why?
| | Female | 81 | 2025 | 73304 | 0.660 |
Why?
| | Software | 3 | 2021 | 665 | 0.630 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 140 | 0.620 |
Why?
| | Diet | 9 | 2025 | 1278 | 0.620 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1062 | 0.620 |
Why?
| | Burns | 4 | 2025 | 325 | 0.620 |
Why?
| | Infant Food | 2 | 2025 | 65 | 0.610 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.610 |
Why?
| | Animals | 56 | 2025 | 36940 | 0.590 |
Why?
| | HIV-1 | 8 | 2024 | 864 | 0.590 |
Why?
| | Adult | 48 | 2025 | 37929 | 0.580 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 136 | 0.580 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 452 | 0.570 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 168 | 0.570 |
Why?
| | Iron | 3 | 2017 | 313 | 0.560 |
Why?
| | Genes, rRNA | 3 | 2015 | 41 | 0.550 |
Why?
| | Middle Aged | 41 | 2025 | 33479 | 0.540 |
Why?
| | Fatty Liver | 2 | 2021 | 243 | 0.540 |
Why?
| | Vagina | 5 | 2016 | 187 | 0.520 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 147 | 0.510 |
Why?
| | Butyrates | 3 | 2024 | 61 | 0.510 |
Why?
| | Membrane Proteins | 3 | 2021 | 1164 | 0.510 |
Why?
| | Mice | 30 | 2025 | 17787 | 0.510 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.500 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 606 | 0.500 |
Why?
| | Nose Diseases | 1 | 2016 | 13 | 0.500 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 17 | 0.490 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 279 | 0.490 |
Why?
| | Case-Control Studies | 15 | 2020 | 3556 | 0.480 |
Why?
| | Base Sequence | 18 | 2015 | 2181 | 0.480 |
Why?
| | Biofilms | 5 | 2016 | 260 | 0.480 |
Why?
| | Cross-Sectional Studies | 16 | 2023 | 5472 | 0.470 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 144 | 0.470 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 68 | 0.460 |
Why?
| | Immunity, Innate | 4 | 2019 | 828 | 0.460 |
Why?
| | Endotoxemia | 2 | 2014 | 86 | 0.460 |
Why?
| | Food | 2 | 2020 | 164 | 0.460 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 160 | 0.440 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 48 | 0.420 |
Why?
| | Genome, Bacterial | 4 | 2016 | 142 | 0.420 |
Why?
| | Computer Graphics | 1 | 2013 | 42 | 0.410 |
Why?
| | Hippocampus | 1 | 2018 | 895 | 0.410 |
Why?
| | Lactobacillus | 4 | 2022 | 29 | 0.410 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 200 | 0.410 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 97 | 0.400 |
Why?
| | Iron, Dietary | 1 | 2013 | 22 | 0.400 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 364 | 0.400 |
Why?
| | Lipid Metabolism | 2 | 2020 | 518 | 0.400 |
Why?
| | Immunoglobulin A | 4 | 2022 | 211 | 0.400 |
Why?
| | Ear, Middle | 6 | 2025 | 85 | 0.390 |
Why?
| | Bacterial Load | 1 | 2012 | 68 | 0.390 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5757 | 0.390 |
Why?
| | Liver | 4 | 2020 | 1943 | 0.390 |
Why?
| | Colitis | 4 | 2025 | 266 | 0.390 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 234 | 0.390 |
Why?
| | Genitalia, Female | 1 | 2012 | 38 | 0.380 |
Why?
| | Probiotics | 5 | 2018 | 54 | 0.380 |
Why?
| | Smoking | 2 | 2020 | 1627 | 0.370 |
Why?
| | Diet, High-Fat | 3 | 2019 | 247 | 0.370 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 209 | 0.370 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1809 | 0.360 |
Why?
| | Genomics | 5 | 2020 | 795 | 0.350 |
Why?
| | Alcohol Drinking | 3 | 2024 | 828 | 0.350 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 394 | 0.350 |
Why?
| | Livestock | 1 | 2010 | 10 | 0.350 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 24 | 0.340 |
Why?
| | Isosorbide Dinitrate | 1 | 2010 | 4 | 0.340 |
Why?
| | Hydralazine | 1 | 2010 | 5 | 0.340 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 184 | 0.340 |
Why?
| | Obesity | 7 | 2023 | 2992 | 0.340 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 9 | 0.330 |
Why?
| | Asthma | 2 | 2015 | 2295 | 0.330 |
Why?
| | Stress, Psychological | 1 | 2018 | 1100 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | DNA Primers | 3 | 2009 | 515 | 0.330 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 56 | 0.330 |
Why?
| | Computational Biology | 3 | 2019 | 644 | 0.330 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 21 | 0.330 |
Why?
| | Bacterial Translocation | 4 | 2019 | 43 | 0.330 |
Why?
| | Escherichia coli | 9 | 2017 | 815 | 0.330 |
Why?
| | Alcohol-Related Disorders | 2 | 2008 | 122 | 0.320 |
Why?
| | Agriculture | 1 | 2010 | 103 | 0.320 |
Why?
| | Fluoroquinolones | 1 | 2009 | 51 | 0.320 |
Why?
| | Weight Loss | 3 | 2021 | 787 | 0.320 |
Why?
| | Genome | 2 | 2009 | 300 | 0.320 |
Why?
| | Catheterization | 2 | 2009 | 179 | 0.320 |
Why?
| | Infant | 17 | 2025 | 9465 | 0.310 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 37 | 0.310 |
Why?
| | Corynebacterium | 4 | 2022 | 49 | 0.300 |
Why?
| | Wound Infection | 1 | 2009 | 32 | 0.300 |
Why?
| | Aged | 19 | 2023 | 23961 | 0.300 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 2 | 0.300 |
Why?
| | Behavior Therapy | 2 | 2021 | 264 | 0.300 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1167 | 0.290 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4295 | 0.290 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 886 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| | Confidentiality | 1 | 2008 | 73 | 0.290 |
Why?
| | Seafood | 2 | 2025 | 28 | 0.290 |
Why?
| | Milk, Human | 4 | 2023 | 158 | 0.280 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 15 | 0.280 |
Why?
| | Transcriptome | 5 | 2021 | 971 | 0.280 |
Why?
| | DNA, Bacterial | 6 | 2017 | 337 | 0.280 |
Why?
| | Pedigree | 4 | 2025 | 514 | 0.280 |
Why?
| | Video Recording | 1 | 2008 | 180 | 0.280 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 177 | 0.280 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 40 | 0.270 |
Why?
| | Pneumonia | 2 | 2025 | 639 | 0.270 |
Why?
| | Genes, Bacterial | 5 | 2018 | 164 | 0.270 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 86 | 0.270 |
Why?
| | Physicians, Primary Care | 1 | 2010 | 236 | 0.270 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 318 | 0.270 |
Why?
| | Congresses as Topic | 1 | 2008 | 233 | 0.260 |
Why?
| | RNA, Transfer | 3 | 1998 | 138 | 0.260 |
Why?
| | Homeostasis | 5 | 2020 | 621 | 0.260 |
Why?
| | Perilipin-2 | 2 | 2017 | 41 | 0.260 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 728 | 0.250 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 58 | 0.250 |
Why?
| | Genotype | 4 | 2019 | 1916 | 0.250 |
Why?
| | Carrier Proteins | 1 | 2010 | 771 | 0.250 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3715 | 0.250 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 88 | 0.250 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1142 | 0.250 |
Why?
| | Dietary Supplements | 3 | 2019 | 561 | 0.240 |
Why?
| | Blueberry Plants | 1 | 2025 | 7 | 0.240 |
Why?
| | Biomarkers | 10 | 2025 | 4149 | 0.240 |
Why?
| | Diet, Western | 3 | 2022 | 81 | 0.240 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2426 | 0.240 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 92 | 0.240 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 548 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Public Health | 1 | 2010 | 588 | 0.240 |
Why?
| | Neoplasms | 2 | 2018 | 2671 | 0.230 |
Why?
| | Research | 1 | 2008 | 451 | 0.230 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 601 | 0.230 |
Why?
| | Attitude of Health Personnel | 2 | 2010 | 1171 | 0.230 |
Why?
| | Phenotype | 8 | 2020 | 3196 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 15 | 0.230 |
Why?
| | Pentanols | 1 | 2024 | 5 | 0.230 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 169 | 0.230 |
Why?
| | Lyases | 1 | 2024 | 12 | 0.220 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 200 | 0.220 |
Why?
| | Palatine Tonsil | 1 | 2024 | 48 | 0.220 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 395 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 539 | 0.220 |
Why?
| | Cohort Studies | 7 | 2022 | 5742 | 0.220 |
Why?
| | Air Microbiology | 2 | 2015 | 47 | 0.220 |
Why?
| | Th17 Cells | 1 | 2025 | 108 | 0.220 |
Why?
| | Glycerophospholipids | 1 | 2024 | 34 | 0.220 |
Why?
| | Adolescent | 14 | 2024 | 21513 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 75 | 0.210 |
Why?
| | Young Adult | 13 | 2024 | 13209 | 0.210 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 166 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 115 | 0.210 |
Why?
| | Pregnancy | 11 | 2025 | 6763 | 0.210 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 30 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 98 | 0.200 |
Why?
| | RNA Splicing | 3 | 1995 | 269 | 0.200 |
Why?
| | RNA, Fungal | 5 | 2002 | 72 | 0.200 |
Why?
| | Ear Canal | 1 | 2003 | 15 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2025 | 229 | 0.200 |
Why?
| | Species Specificity | 4 | 2020 | 585 | 0.200 |
Why?
| | Ribonuclease P | 7 | 2001 | 22 | 0.200 |
Why?
| | Fungal Proteins | 2 | 2000 | 123 | 0.200 |
Why?
| | Sepsis | 2 | 2023 | 617 | 0.200 |
Why?
| | Mass Screening | 2 | 2008 | 1287 | 0.200 |
Why?
| | Gene Ontology | 1 | 2022 | 53 | 0.190 |
Why?
| | Mice, Knockout | 6 | 2025 | 3015 | 0.190 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.190 |
Why?
| | Olfaction Disorders | 1 | 2023 | 63 | 0.190 |
Why?
| | Disease Susceptibility | 3 | 2020 | 347 | 0.190 |
Why?
| | Genetic Variation | 4 | 2018 | 991 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2025 | 257 | 0.190 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 10 | 0.190 |
Why?
| | Mycobacterium | 1 | 2023 | 108 | 0.190 |
Why?
| | Exome | 2 | 2020 | 231 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 385 | 0.190 |
Why?
| | Immunity | 2 | 2014 | 143 | 0.190 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 117 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 496 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1091 | 0.180 |
Why?
| | Child, Preschool | 10 | 2025 | 11074 | 0.180 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 14 | 0.180 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 55 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 42 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 220 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 195 | 0.180 |
Why?
| | Genes, Fungal | 4 | 2000 | 52 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Child | 12 | 2025 | 21935 | 0.170 |
Why?
| | Nutritional Status | 2 | 2014 | 350 | 0.170 |
Why?
| | Health | 2 | 2012 | 84 | 0.170 |
Why?
| | Ascomycota | 1 | 2000 | 31 | 0.170 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 30 | 0.170 |
Why?
| | Islets of Langerhans | 3 | 2015 | 803 | 0.170 |
Why?
| | Firmicutes | 2 | 2021 | 19 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Mice, Nude | 1 | 2022 | 698 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.160 |
Why?
| | Carcinogenesis | 1 | 2022 | 217 | 0.160 |
Why?
| | Mouth | 1 | 2020 | 87 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 557 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 293 | 0.160 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.160 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.160 |
Why?
| | Aged, 80 and over | 6 | 2021 | 7635 | 0.160 |
Why?
| | Body Mass Index | 5 | 2020 | 2389 | 0.160 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 117 | 0.160 |
Why?
| | Vascular Remodeling | 1 | 2021 | 193 | 0.160 |
Why?
| | Double-Blind Method | 4 | 2025 | 1993 | 0.160 |
Why?
| | Autoimmunity | 3 | 2015 | 908 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 10 | 0.160 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 51 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2025 | 6079 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 261 | 0.150 |
Why?
| | Surveys and Questionnaires | 3 | 2009 | 5778 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 44 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 176 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Restraint, Physical | 1 | 2018 | 72 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 124 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2189 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 363 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 341 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Microbiological Techniques | 2 | 2016 | 30 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 128 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2111 | 0.140 |
Why?
| | Rats | 8 | 2023 | 5647 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 106 | 0.140 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.140 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 120 | 0.140 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 23 | 0.140 |
Why?
| | Ethanol | 1 | 2022 | 608 | 0.140 |
Why?
| | Immunoglobulin D | 1 | 2017 | 30 | 0.140 |
Why?
| | Evolution, Molecular | 2 | 2018 | 493 | 0.140 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.140 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 7 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.140 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 186 | 0.140 |
Why?
| | Cytokines | 5 | 2025 | 2085 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2018 | 125 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2018 | 106 | 0.140 |
Why?
| | Birth Weight | 1 | 2020 | 516 | 0.140 |
Why?
| | Lung | 4 | 2022 | 4060 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7604 | 0.130 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 43 | 0.130 |
Why?
| | Water Microbiology | 3 | 2016 | 85 | 0.130 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 99 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Ceftriaxone | 1 | 2016 | 21 | 0.130 |
Why?
| | Metals | 1 | 1997 | 136 | 0.130 |
Why?
| | Micronutrients | 1 | 2017 | 92 | 0.130 |
Why?
| | Autoantibodies | 3 | 2022 | 1496 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 496 | 0.130 |
Why?
| | Gene Expression | 2 | 2018 | 1502 | 0.130 |
Why?
| | beta-Lactamases | 1 | 2016 | 48 | 0.130 |
Why?
| | Metabolome | 1 | 2020 | 350 | 0.130 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 19 | 0.130 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 51 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 57 | 0.120 |
Why?
| | Bacillus | 1 | 2015 | 16 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 124 | 0.120 |
Why?
| | Binding Sites | 6 | 1998 | 1303 | 0.120 |
Why?
| | Cholesterol | 3 | 2023 | 410 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 10 | 0.120 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 132 | 0.120 |
Why?
| | Symbiosis | 2 | 2017 | 79 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 77 | 0.120 |
Why?
| | Gelatin | 1 | 2016 | 52 | 0.120 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.120 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 660 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | RNA, Messenger | 4 | 2018 | 2833 | 0.120 |
Why?
| | Interleukin-6 | 2 | 2017 | 778 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 304 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 40 | 0.120 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.120 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 24 | 0.120 |
Why?
| | Catalase | 1 | 2015 | 130 | 0.120 |
Why?
| | Metagenomics | 2 | 2019 | 169 | 0.120 |
Why?
| | Thrombophilia | 1 | 2016 | 83 | 0.120 |
Why?
| | Hospitalization | 3 | 2018 | 2199 | 0.120 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 61 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 252 | 0.120 |
Why?
| | Hysterectomy | 1 | 2016 | 129 | 0.120 |
Why?
| | Thrombin | 1 | 2016 | 152 | 0.120 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 65 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 84 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 39 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 183 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 185 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2031 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 148 | 0.120 |
Why?
| | Carrier State | 1 | 2015 | 67 | 0.110 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 93 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.110 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 100 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 50 | 0.110 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 111 | 0.110 |
Why?
| | Gentamicins | 1 | 2015 | 54 | 0.110 |
Why?
| | Physical Exertion | 1 | 2015 | 215 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 228 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 236 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 119 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2015 | 125 | 0.110 |
Why?
| | Bifidobacterium | 3 | 2022 | 20 | 0.110 |
Why?
| | Biota | 1 | 2014 | 34 | 0.110 |
Why?
| | Genetics, Medical | 2 | 2011 | 26 | 0.110 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.110 |
Why?
| | Adiposity | 2 | 2018 | 518 | 0.110 |
Why?
| | Maternal Welfare | 1 | 2014 | 21 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1112 | 0.110 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 1040 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 617 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 605 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 142 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 44 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 976 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 985 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1040 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 33 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 59 | 0.110 |
Why?
| | Preconception Care | 1 | 2014 | 43 | 0.100 |
Why?
| | Nutrition Assessment | 1 | 2014 | 92 | 0.100 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 167 | 0.100 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 24 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 806 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 218 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 601 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 119 | 0.100 |
Why?
| | Drug Combinations | 2 | 2012 | 343 | 0.100 |
Why?
| | Zinc Fingers | 1 | 1992 | 50 | 0.100 |
Why?
| | Burkina Faso | 1 | 2012 | 7 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 683 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 584 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 625 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 267 | 0.090 |
Why?
| | Aerosols | 1 | 2013 | 176 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 64 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2018 | 879 | 0.090 |
Why?
| | Skin | 1 | 2016 | 752 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 140 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 740 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 294 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 539 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 166 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 767 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 565 | 0.090 |
Why?
| | Lactation | 1 | 2012 | 181 | 0.090 |
Why?
| | Viruses | 1 | 2012 | 113 | 0.090 |
Why?
| | Nutritive Value | 1 | 2010 | 37 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1468 | 0.080 |
Why?
| | Food Safety | 1 | 2010 | 22 | 0.080 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 264 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 409 | 0.080 |
Why?
| | Amphotericin B | 1 | 2010 | 31 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2010 | 30 | 0.080 |
Why?
| | Insulin | 2 | 2022 | 2409 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1910 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 30 | 0.080 |
Why?
| | Risk Factors | 4 | 2018 | 10388 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 83 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 77 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2018 | 10811 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 499 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 33 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1430 | 0.080 |
Why?
| | Biomass | 1 | 2009 | 118 | 0.080 |
Why?
| | Montana | 1 | 2009 | 20 | 0.080 |
Why?
| | Mississippi | 1 | 2009 | 21 | 0.080 |
Why?
| | Prostatectomy | 1 | 2009 | 104 | 0.080 |
Why?
| | Sequence Alignment | 3 | 2001 | 343 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 91 | 0.080 |
Why?
| | Fatty Acids | 3 | 2022 | 443 | 0.080 |
Why?
| | Prevalence | 2 | 2014 | 2734 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2022 | 15657 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2017 | 1178 | 0.080 |
Why?
| | Permeability | 2 | 2022 | 161 | 0.080 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 143 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 900 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 669 | 0.070 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 114 | 0.070 |
Why?
| | Systems Integration | 1 | 2008 | 37 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 325 | 0.070 |
Why?
| | Environment | 1 | 2010 | 358 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1946 | 0.070 |
Why?
| | Housing | 1 | 2009 | 146 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 657 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2531 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 73 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 154 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2607 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2844 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 596 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 118 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 46 | 0.070 |
Why?
| | Prognosis | 2 | 2020 | 4030 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 762 | 0.070 |
Why?
| | Physicians, Family | 1 | 2009 | 201 | 0.070 |
Why?
| | Child Development | 1 | 2012 | 475 | 0.070 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 188 | 0.070 |
Why?
| | Focus Groups | 1 | 2010 | 522 | 0.070 |
Why?
| | Plasmids | 4 | 2016 | 363 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2010 | 351 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 256 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 225 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3284 | 0.060 |
Why?
| | Research Personnel | 1 | 2008 | 173 | 0.060 |
Why?
| | Indomethacin | 1 | 2006 | 81 | 0.060 |
Why?
| | Peptic Ulcer | 1 | 2006 | 20 | 0.060 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 26 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 570 | 0.060 |
Why?
| | Proteobacteria | 2 | 2017 | 15 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 46 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 29 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 118 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 430 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 893 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 500 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 843 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 195 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 156 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 17 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 26 | 0.060 |
Why?
| | Artificial Intelligence | 1 | 2008 | 279 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 61 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 534 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1114 | 0.060 |
Why?
| | Hexanols | 1 | 2024 | 4 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 684 | 0.060 |
Why?
| | Oropharynx | 1 | 2024 | 46 | 0.060 |
Why?
| | Fruit | 1 | 2025 | 140 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2005 | 316 | 0.060 |
Why?
| | Age Factors | 2 | 2025 | 3295 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 317 | 0.060 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 88 | 0.060 |
Why?
| | Methylamines | 1 | 2024 | 34 | 0.060 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 200 | 0.050 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 62 | 0.050 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 70 | 0.050 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 180 | 0.050 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 163 | 0.050 |
Why?
| | Comorbidity | 1 | 2009 | 1622 | 0.050 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 11 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 32 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 83 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 53 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 33 | 0.050 |
Why?
| | Cats | 1 | 2004 | 210 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 350 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1786 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1242 | 0.050 |
Why?
| | Choline | 1 | 2024 | 127 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 560 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2486 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 119 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 600 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 10 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 849 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1710 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 466 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 55 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 228 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 48 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 183 | 0.050 |
Why?
| | Smell | 1 | 2023 | 117 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 94 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 314 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 267 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2002 | 96 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1704 | 0.050 |
Why?
| | Japan | 1 | 2021 | 115 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 375 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 50 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 198 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 116 | 0.050 |
Why?
| | Pigments, Biological | 1 | 2001 | 16 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 405 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 452 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 664 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2021 | 89 | 0.040 |
Why?
| | RNA, Archaeal | 1 | 2001 | 16 | 0.040 |
Why?
| | Systole | 1 | 2021 | 189 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 143 | 0.040 |
Why?
| | Tight Junctions | 1 | 2021 | 76 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 21 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 145 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 73 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5131 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1547 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 248 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 88 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 80 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 390 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 363 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 93 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 105 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 455 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1738 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 124 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 65 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 207 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 552 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 77 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 281 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 115 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 165 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 366 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 307 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 155 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 180 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6828 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 136 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3958 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 372 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 34 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 242 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 672 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 123 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 3 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 188 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 53 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 4 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 125 | 0.040 |
Why?
| | Acute Disease | 2 | 2016 | 1007 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 156 | 0.030 |
Why?
| | Syndecan-1 | 1 | 2017 | 38 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 597 | 0.030 |
Why?
| | Powders | 1 | 2017 | 43 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 564 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 78 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 71 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 163 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 455 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 480 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1020 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 79 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 7 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1272 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 89 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 67 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 29 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 213 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 38 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 816 | 0.030 |
Why?
| | Heart Failure | 1 | 2010 | 2236 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 118 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 64 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Primary Health Care | 1 | 2007 | 1738 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 788 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 268 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 5 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2828 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 499 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 23 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 289 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 810 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 785 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 67 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 26 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 356 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 184 | 0.030 |
Why?
| | North America | 1 | 2016 | 313 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 48 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 361 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 88 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 635 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 58 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 32 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 514 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 22 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1060 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 89 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 171 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 3 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 5 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 678 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 30 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 47 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 425 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 491 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 76 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 102 | 0.030 |
Why?
| | Methane | 1 | 2014 | 49 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2057 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 286 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 32 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 63 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 384 | 0.030 |
Why?
| | Geography | 1 | 2014 | 200 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 178 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 343 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 600 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 24 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1994 | 183 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 269 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 350 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 257 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 342 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 409 | 0.030 |
Why?
| | New York City | 1 | 2013 | 85 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 184 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 1992 | 15 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 547 | 0.030 |
Why?
| | Genes, Lethal | 1 | 1992 | 30 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2847 | 0.020 |
Why?
| | Staphylococcus | 1 | 2013 | 76 | 0.020 |
Why?
| | Endoscopy | 1 | 2015 | 318 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 362 | 0.020 |
Why?
| | Cattle | 2 | 2005 | 984 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1864 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 500 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 316 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 185 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1509 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 754 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 48 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 307 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 521 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 431 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 385 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 99 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2757 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 622 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 483 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 789 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1317 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 422 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5079 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 405 | 0.020 |
Why?
| | Milk | 1 | 2012 | 124 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 617 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 129 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 417 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 108 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 437 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 237 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3457 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2186 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 691 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 910 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1226 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 622 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1129 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1316 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2892 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 7 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 466 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 844 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 412 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 305 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 37 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 15 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 201 | 0.020 |
Why?
| | Clinical Medicine | 1 | 2009 | 25 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3566 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2139 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1774 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1502 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Washington | 1 | 2007 | 156 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1381 | 0.020 |
Why?
| | RNA | 1 | 2013 | 921 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 29 | 0.020 |
Why?
| | Internal Medicine | 1 | 2009 | 265 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 985 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1101 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 692 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 497 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2475 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2005 | 158 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 14 | 0.010 |
Why?
| | Culture Media | 1 | 2005 | 165 | 0.010 |
Why?
| | United States | 2 | 2015 | 14841 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 547 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 305 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 141 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 121 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.010 |
Why?
| | Risk-Taking | 1 | 2007 | 348 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 2654 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 934 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 117 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 311 | 0.010 |
Why?
| | Psychometrics | 1 | 2007 | 720 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2007 | 546 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 80 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 46 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1066 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1236 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2009 | 1313 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 52 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 527 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 177 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 66 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 25 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 53 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 179 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1670 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4193 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 491 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 28 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 45 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 83 | 0.010 |
Why?
| | Genes | 1 | 1989 | 230 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 319 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1353 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|